The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant/adjuvant pembrolizumab and surgery + cesium-131 in recurrent HNSCC: A multicenter phase I/IIb trial.
 
Emma De Ravin
No Relationships to Disclose
 
Hani Samarah
No Relationships to Disclose
 
Jennifer Johnson
Consulting or Advisory Role - Foundation Medicine; Rakuten Medical
Research Funding - Bristol-Myers Squibb
(OPTIONAL) Uncompensated Relationships - Taproot Health Inc
 
Trisha Wise-Draper
Stock and Other Ownership Interests - High Enroll
Consulting or Advisory Role - Adaptimmune; Adlai Nortye; Caris Life Sciences; EMD Serono; Genmab; Merck; Need; Replimune
Research Funding - AstraZeneca/MedImmune; Bristol-Myers Squibb; Caris Life Sciences; GlaxoSmithKline; GlaxoSmithKline; Janssen Oncology; Merck
Travel, Accommodations, Expenses - Caris Life Sciences
 
Voichita Bar-Ad
No Relationships to Disclose
 
Alice Tang
No Relationships to Disclose
 
Adam Luginbuhl
Research Funding - Bristol-Myers Squibb
 
Chad Zender
No Relationships to Disclose